People living with HIV’s perspectives of acceptability of fee for home delivery of ART: a qualitative study

Introduction Significant progress has been made in the HIV response in South Africa; however, gaps remain in ensuring engagement in care to support life-long medication adherence and viral suppression.

The National Department of Health (NDoH) has introduced community-based and clinic-based HIV differentiated service delivery (DSD) models to tackle suboptimal adherence and retention in care.

Nevertheless, differentiated care models require adaptation to better serve clients who struggle with adherence.

There is limited research on the acceptability of fee for home delivery of ART in resource-constrained settings.

The current study investigates the acceptability of fee for home delivery of ART among people living with HIV in South Africa.

Methods Two mixed-gender focus group discussions (FGDs) took place between June and November 2019, consisting of 10 participants in each group.

A purposive sampling strategy was employed to identify and select 10 people living with HIV who were ART-eligible but not in care, and 10 people living with HIV who were currently taking ART and in care.

Participants were grouped according to their treatment status.

A coding framework, informed by a priori categories and derived from topics in the interview guide, was developed and utilized to facilitate analysis.

Results Participants expressed enthusiasm for having ART home-delivered, as it would save the time spent waiting in long queues at the clinic.

However, some participants raised concerns about potential payment difficulties due to high unemployment rates in the community.

Some participants believed this would be acceptable, as patients already incur costs for travel and food when visiting the clinic.

Participants in both FGDs expressed strong concerns about home delivery of their ART based on fear of accidental disclosure, especially for those who have not disclosed to their immediate families and partners.

Conclusion Our study suggests that charging a fee for home delivery is an acceptable and innovative approach to supporting PLHIV in maintaining adherence to their medication and remaining in care.